Literature DB >> 27511139

Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors' reply.

P P Gounder1, L R Bulkow2, B J McMahon2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27511139      PMCID： PMC5048404          DOI： 10.1111/apt.13730

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  6 in total

1.  Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma.

Authors:  Y C Chen; Y F Liaw
Journal:  Aliment Pharmacol Ther       Date:  2016-07       Impact factor: 8.171

2.  Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma.

Authors:  Man-Fung Yuen; Erwin Sablon; He-Jun Yuan; Danny Ka-Ho Wong; Chee-Kin Hui; Benjamin Chun-Yu Wong; Annie On-On Chan; Ching Lung Lai
Journal:  Hepatology       Date:  2003-03       Impact factor: 17.425

3.  Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F.

Authors:  Stephen E Livingston; Josephine P Simonetti; Lisa R Bulkow; Chriss E Homan; Mary M Snowball; Henry H Cagle; Susan E Negus; Brian J McMahon
Journal:  Gastroenterology       Date:  2007-08-02       Impact factor: 22.682

4.  Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.

Authors:  P P Gounder; L R Bulkow; M Snowball; S Negus; P R Spradling; B C Simons; B J McMahon
Journal:  Aliment Pharmacol Ther       Date:  2016-04-08       Impact factor: 8.171

5.  HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.

Authors:  Man-Fung Yuen; Danny Ka-Ho Wong; James Fung; Philip Ip; David But; Ivan Hung; Kevin Lau; John Chi-Hang Yuen; Ching-Lung Lai
Journal:  Gastroenterology       Date:  2008-07-16       Impact factor: 22.682

6.  Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska Native people.

Authors:  Lance K Ching; Prabhu P Gounder; Lisa Bulkow; Philip R Spradling; Michael G Bruce; Susan Negus; Mary Snowball; Brian J McMahon
Journal:  Liver Int       Date:  2016-04-06       Impact factor: 5.828
  6 in total
  1 in total

1.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors:  Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal:  Hepatology       Date:  2018-04       Impact factor: 17.425
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.